Glaucoma News and Research

Latest Glaucoma News and Research

A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

A ubiquitous protein called sigma 1 receptor, which is known to protect cells from stress, appears key to the function and survival of the neurons most impacted by glaucoma, scientists report.

1 Mar 2022

Mechanism behind how certain osmolytes cause kidney damage revealed

Researchers from Tokyo Metropolitan University have uncovered the mechanism by which osmolytes used to treat high fluid pressure in the eye and skull can cause kidney damage.

27 Feb 2022

Cognitive impairment in patients with long-COVID can be improved using brain stimulation

Many recovered COVID-19 patients continue to exhibit significant and long-lasting cognitive deficits in memory, attention, language comprehension and multitasking, as well as fatigue.

7 Feb 2022

New study offers valuable information on ocular drug metabolism and pharmacokinetics

Severe visual illnesses are increasing in our society, and effective treatments are missing for diseases as age-related macular degeneration, diabetic retinopathy, and glaucoma. Both industry and academia are highly interested to advance ocular drug discovery and development.

29 Jan 2022

Medical marijuana users brace for shortages as Montana’s recreational market opens

More than a year after voters approved legalizing marijuana for recreational use in Montana, anyone older than 21 can now enter a dispensary and buy cannabis. That has medical marijuana user Joylynn Mane Wright worried.

5 Jan 2022

Ophthalmology professor receives $75,000 grant to support international collaborations on eye research

Steven DeVries, MD, PhD, the David Shoch, MD, PhD, professor of Ophthalmology, has received an International Research Collaborators Award from Research to Prevent Blindness.

14 Dec 2021

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Researchers from the Duke Molecular Physiology Institute have been investigating genetic associations with more severe disease and examining the associations that certain genetic features have with other diseases.

13 Dec 2021

Infantile cataracts are more common and problematic than thought

Three days after Canyon Brown was born, the attending pediatrician discovered a problem.

8 Dec 2021

Cataract surgery associated with lower risk of dementia

Cataracts affect most older adults at risk for dementia, and now researchers are finding strong evidence that cataract surgery is associated with a lower risk of developing dementia.

6 Dec 2021

NEI researchers identify unique population of B cells that tamps down the immune system

Researchers at the National Eye Institute (NEI) have identified, isolated, and characterized a unique population of B cells that tamps down the immune system, reducing chronic inflammation.

2 Dec 2021

Stranded by the pandemic, he had only travel insurance. It left him with a $38,000 bill.

Duy Hoa Tran, a retired Vietnamese schoolteacher, arrived in Los Angeles in February 2020 to visit his daughter and 2-month-old grandson.

18 Nov 2021

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

A new study investigates the presence of SARS-CoV-2 in tears and eye secretions and describes the ocular symptoms in patients with COVID-19.

31 Oct 2021

New project investigates stem cell therapy as a potential treatment for glaucoma

Oregon Health & Science University is part of a national research project investigating stem cell therapy as a potential treatment for glaucoma, the world's second leading cause of blindness.

29 Oct 2021

Laser treatment shows potential to transform glaucoma management in Africa

Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and incidence, suggests new research published in Lancet Global Health.

15 Oct 2021

New study finds SARS-CoV-2 causes retinal infection

Can coronavirus disease 2019 (COVID-19) affect the eye? New research suggests the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can enter the eye and infect photoreceptor and retinal ganglion cells. In addition, SARS-CoV-2 infection increases the expression of several inflammatory genes, including the cytokine interleukin 33 (IL33), which is linked to COVID-19 disease and retinal degeneration.

13 Oct 2021

New method could provide in-depth understanding of the brain's visual sensory thalamus

Neuroscientists at Technische Universität Dresden discovered a novel, non-invasive imaging-based method to investigate the visual sensory thalamus, an important structure of the human brain and point of origin of visual difficulties in diseases such as dyslexia and glaucoma.

8 Oct 2021

Australian researchers hope to switch on sight with new gene therapy

Australian researchers are developing a new gene therapy which they hope will ‘switch on sight’ by regenerating light-sensing photoreceptor cells in the retina at the back of the eye.

7 Oct 2021

Popular class of diabetes medications may be protective against glaucoma

A popular class of diabetes medications called GLP-1R agonists (Trulicity and Rybelsus) may also protect against glaucoma in diabetic patients, according to a new study led by researchers in the Scheie Eye Institute at the University of Pennsylvania's Perelman School of Medicine.

20 Sep 2021

Common eye test could expel tear droplets that may spread viruses, other pathogens

A common eye test could expel tear droplets up to a meter away from the patient, potentially spreading viruses that cause COVID-19 and other pathogens.

14 Sep 2021

Eye conditions linked to increased risk of dementia

Age-related macular degeneration, cataract and diabetes-related eye disease are linked to an increased risk of dementia, suggests research published online in the British Journal of Ophthalmology.

14 Sep 2021

Glaucoma News and Research

Latest Glaucoma News and Research

A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

Mechanism behind how certain osmolytes cause kidney damage revealed

Cognitive impairment in patients with long-COVID can be improved using brain stimulation

New study offers valuable information on ocular drug metabolism and pharmacokinetics

Medical marijuana users brace for shortages as Montana’s recreational market opens

Ophthalmology professor receives $75,000 grant to support international collaborations on eye research

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Infantile cataracts are more common and problematic than thought

Cataract surgery associated with lower risk of dementia

NEI researchers identify unique population of B cells that tamps down the immune system

Stranded by the pandemic, he had only travel insurance. It left him with a $38,000 bill.

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

New project investigates stem cell therapy as a potential treatment for glaucoma

Laser treatment shows potential to transform glaucoma management in Africa

New study finds SARS-CoV-2 causes retinal infection

New method could provide in-depth understanding of the brain's visual sensory thalamus

Australian researchers hope to switch on sight with new gene therapy

Popular class of diabetes medications may be protective against glaucoma

Common eye test could expel tear droplets that may spread viruses, other pathogens

Eye conditions linked to increased risk of dementia

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Glaucoma News and Research

Latest Glaucoma News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in